EFFECTS OF DIABETES ON CARDIAC CONTRACTILE PROTEINS AND REVERSAL WITH INSULIN
Main Article Content
Keywords
Diabetes, cardiac contractile proteins, insulin therapy, glycemic control, cardiac function, diabetic cardiomyopathy.
Abstract
Introduction: Diabetes mellitus poses a serious threat to global health due to its well-known devastating effects on the cardiovascular system. A crucial part of preserving circulatory homeostasis is the contractile activity of the heart, which is controlled by cardiac contractile proteins. However, research is still ongoing into the processes by which diabetes alters these proteins and the possibility of their reversal with insulin therapy.
Methods: In the medicine department of Central Park Medical College & Teaching Hospital, Lahore Pakistan, a 9-month prospective longitudinal research was conducted. Glycemic control, cardiac contractile proteins, and heart function were carefully examined at baseline and nine months in a group of 150 adult individuals. For comparison analysis, participants were divided into diabetes groups with and without insulin therapy as well as a control group.
Results: Both diabetic groups showed improved glycemic control, with HbA1c levels in the diabetic insulin group (DIG) falling from 8.3% to 7.9%. The Diabetic Group's (DG) fasting blood glucose levels dropped from 166.2 mg/dL to 158.4 mg/dL. According to an enhanced ejection fraction in DG that rose from 58.0% to 59.7% and a slight shortening of the QTc interval, the study also showed possible improvements in cardiac function. Additionally, actin levels in DIG increased statistically significantly from 18.8 g/g to 20.3 g/g, indicating a potential reversal of cardiac protein changes.
Conclusion: The importance of glycemic management and the potential of insulin therapy in maintaining or recovering heart function in diabetics are both highlighted by this study. It adds to the growing body of research that highlights the need of comprehensive diabetes treatment for treating and preventing cardiac problems linked to diabetes.
References
2. Nguyen TD, Schwarzer M, Schrepper A, Amorim PA, Blum D, Hain C, Faerber G, Haendeler J, Altschmied J, Doenst T. Increased Protein Tyrosine Phosphatase 1B (PTP 1B) Activity and Cardiac Insulin Resistance Precede Mitochondrial and Contractile Dysfunction in Pressure‐ Overloaded Hearts. Journal of the American Heart Association. 2018 Jul 3;7(13):e008865.
3. Wang Q, Liu Y, Fu Q, Xu B, Zhang Y, Kim S, Tan R, Barbagallo F, West T, Anderson E, Wei
W. Inhibiting insulin-mediated β2-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction. Circulation. 2017 Jan 3;135(1):73-88.
4. Riehle C, Abel ED. Insulin signaling and heart failure. Circulation research. 2016 Apr 1;118(7):1151-69.
5. Singh S, Netticadan T, Ramdath DD. Expression of cardiac insulin signalling genes and proteins in rats fed a high-sucrose diet: effect of bilberry anthocyanin extract. Genes & Nutrition. 2016 Dec;11(1):1-2.
6. Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia-and insulin- resistance-induced heart disease. Diabetologia. 2018 Jan;61(1):21-8.
7. Fu Q, Wang Q, Xiang YK. Insulin and β adrenergic receptor signaling: crosstalk in heart. Trends in Endocrinology & Metabolism. 2017 Jun 1;28(6):416-27.
8. Wu D, Ren P, Zheng Y, Zhang L, Xu G, Xie W, Lloyd EE, Zhang S, Zhang Q, Curci JA, Coselli JS. NLRP3 (nucleotide oligomerization domain–like receptor family, pyrin domain containing 3)–caspase-1 inflammasome degrades contractile proteins: implications for aortic biomechanical dysfunction and aneurysm and dissection formation. Arteriosclerosis, thrombosis, and vascular biology. 2017 Apr;37(4):694-706.
9. Fu Q, Shi Q, West TM, Xiang YK. Cross-talk between insulin signaling and GPCRs. Journal of cardiovascular pharmacology. 2017 Aug;70(2):74.
10. Bell DS, Goncalves E. Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications. Diabetes, Obesity and Metabolism. 2019 Jun;21(6):1277-90.
11. Wang S, Schianchi F, Neumann D, Wong LY, Sun A, van Nieuwenhoven FA, Zeegers MP, Strzelecka A, Col U, Glatz JF, Nabben M. Specific amino acid supplementation rescues the heart from lipid overload-induced insulin resistance and contractile dysfunction by targeting the endosomal mTOR–v-ATPase axis. Molecular Metabolism. 2021 Nov 1;53:101293.
12. Wang Q, Ren J. mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: Role of p38 MAPK and Foxo1. Pharmacological research. 2016 Sep 1;111:357-73.
13. Perry BD, Caldow MK, Brennan-Speranza TC, Sbaraglia M, Jerums G, Garnham A, Wong C, Levinger P, ul Haq MA, Hare DL, Price SR. Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exercise immunology review. 2016;22:94.
14. Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circulation research. 2018 Feb 16;122(4):624-38.
15. Chong CR, Clarke K, Levelt E. Metabolic remodelling in diabetic cardiomyopathy. Cardiovascular research. 2017 Mar 15;113(4):422-30.
16. Gargiulo P, Perrone-Filardi P. Heart failure, whole-body insulin resistance and myocardial insulin resistance: an intriguing puzzle. Journal of Nuclear Cardiology. 2018 Feb;25:177-80.
17. Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nature Reviews Cardiology. 2021 Dec;18(12):809-23.
18. Qin CX, Sleaby R, Davidoff AJ, Bell JR, De Blasio MJ, Delbridge LM, Chatham JC, Ritchie RH. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications. Pharmacological Research. 2017 Feb 1;116:45- 56.
19. Al Kury LT. Calcium homeostasis in ventricular myocytes of diabetic cardiomyopathy. Journal of Diabetes Research. 2020 Nov 13;2020.
20. Bombicz M, Priksz D, Gesztelyi R, Kiss R, Hollos N, Varga B, Nemeth J, Toth A, Papp Z, Szilvassy Z, Juhasz B. The drug candidate BGP-15 delays the onset of diastolic dysfunction in the Goto-Kakizaki rat model of diabetic cardiomyopathy. Molecules. 2019 Feb 7;24(3):586..
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Adnan Ali
Assistant Professor of Medicine and Endocrinologist, Central Park Medical College & Teaching Hospital, Lahore Pakistan
Sumaiya Muhammad Iqbal Memon
Senior Registrar Emergency Department, NICVD, Karachi Pakistan
Badar Munir
Medical Officer, Saadat Medical Complex, Narowal, Pakistan
Maeesa Wadood
Associate Professor, Department of Pathology, Baqai Medical University, Karachi Pakistan
Muhammad Rizwan
Associate Professor, Baqai Institute of Hematology, Baqai Medical University, Karachi Pakistan
Shahid Pervez Shaikh
Associate Professor Anatomy, Baqai Medical University, Karachi, Pakistan